Aureus Asset Management, LLC Bristol Myers Squibb CO Transaction History

Aureus Asset Management, LLC

$1.51 Billion
Q3 2024

A detailed history of Aureus Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aureus Asset Management, LLC holds 4,893 shares of BMY stock, worth $282,619. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,893

Holding current value

$282,619

% of portfolio

0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $194,056 - $253,212	4,893 New	4,893 $253,000
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $59,687 - $67,673	-1,244 Reduced 15.23%	6,922 $375,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $1.92 Million - $2.14 Million	-33,087 Reduced 80.21%	8,166 $473,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $71,164 - $79,016	-1,117 Reduced 2.64%	41,253 $2.64 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $4,074 - $4,620	62 Added 0.15%	42,370 $2.94 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $367,806 - $435,534	5,371 Added 14.54%	42,308 $3.04 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $1.62 Million - $1.78 Million	22,266 Added 151.77%	36,937 $2.84 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $6,455 - $7,740	105 Added 0.72%	14,671 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.18 Million - $1.37 Million	-21,940 Reduced 60.1%	14,566 $908,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $2.26 Million - $2.46 Million	36,506 New	36,506 $2.44 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $297,938 - $337,618	-5,160 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $17,803 - $19,728	-310 Reduced 5.67%	5,160 $311,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $32,892 - $38,454	-600 Reduced 9.88%	5,470 $322,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $9,280 - $13,486	-200 Reduced 3.19%	6,070 $338,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $9,842 - $12,838	200 Added 3.29%	6,270 $402,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $109,452 - $121,031	-2,453 Reduced 28.78%	6,070 $275,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $6.35 Million - $7.57 Million	-140,728 Reduced 94.29%	8,523 $407,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $3.39 Million - $4.39 Million	-69,480 Reduced 31.77%	149,251 $7.76 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $823,710 - $929,081	14,925 Added 7.32%	218,731 $13.6 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $251,892 - $313,955	4,985 Added 2.51%	203,806 $11.3 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $153,934 - $177,209	-2,569 Reduced 1.28%	198,821 $12.6 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $35,424 - $38,621	-591 Reduced 0.29%	201,390 $12.3 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $11.2 Million - $12.9 Million	201,981	201,981 $12.9 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.

Account

Aureus Asset Management, LLC Bristol Myers Squibb CO Transaction History